Join us on October 2nd for part one of our PK 101 webinar series. Nuventra’s Mark Bush, PhD, will lead the session titled, “PK 101: Introducing Pharmacokinetic Concepts & Noncompartmental Analysis.” Dr. Bush has over 20 years of experience in clinical pharmacology and pharmacokinetics with a particular focus in clinical pharmacology study design and interpretation.
Part one of this PK 101 series will cover pharmacokinetics (PK) and noncompartmental analysis (NCA) fundamentals including:
- PK overview
- Routes of administration
- Key NCA parameters
- Area under the curve
- PK parameters from AUC
- And more
Pharmacokinetic data contributes to much of what is on a drug package label. Noncompartmental analysis provides the most elementary information for a drug (i.e., the rate and extent of absorption and elimination). PK data and NCAs are essential for characterizing new drug products and can help guide development at each stage of the process.
Meet the Presenter
Mark A. Bush, Ph.D.
Associate Vice President, Clinical Pharmacology & Pharmacokinetics
Dr. Bush has over 20 years of experience in Clinical Pharmacology and Pharmacokinetics with a particular focus in clinical pharmacology study design and interpretation. His therapeutic concentrations include Endocrinology and Metabolism in early phases of development. Dr. Bush has worked on over 100 PK and Population PK analyses.